Cargando…

Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort

Metabolic abnormalities have been associated with olanzapine treatment. We assessed if olanzapine has dose‐dependent effects on metabolic parameters with changes for weight, blood pressure, lipid and glucose profiles being modelled using linear mixed‐effects models. The risk of metabolic abnormaliti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoretsanitis, Georgios, Dubath, Céline, Grosu, Claire, Piras, Marianna, Laaboub, Nermine, Ranjbar, Setareh, Ansermot, Nicolas, Crettol, Séverine, Vandenberghe, Frederik, Gamma, Franziska, von Gunten, Armin, Plessen, Kerstin Jessica, Seifritz, Erich, Conus, Philippe, Eap, Chin B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305461/ https://www.ncbi.nlm.nih.gov/pubmed/35150056 http://dx.doi.org/10.1111/bcpt.13715

Ejemplares similares

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis
por: Sjaarda, Jennifer, et al.
Publicado: (2023)

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort
por: Laaboub, Nermine, et al.
Publicado: (2021)

Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study
por: Piras, Marianna, et al.
Publicado: (2023)

Effects of psychotropic switches on weight change: a prospective cohort study
por: Piras, M., et al.
Publicado: (2022)

Metabolic disturbances are associated with psychiatric readmission: results from a Swiss psychiatric cohort
por: Laaboub, N., et al.
Publicado: (2022)

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
por: Delacrétaz, Aurélie, et al.
Publicado: (2018)

DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study
por: Dubath, C., et al.
Publicado: (2022)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Addition of Aripiprazole to the Clozapine May Be Useful in Reducing Anxiety in Treatment-Resistant Schizophrenia
por: Chanachev, Aleksandar, et al.
Publicado: (2011)

Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity
por: Guinchat, Vincent, et al.
Publicado: (2022)

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients
por: Delacrétaz, Aurélie, et al.
Publicado: (2019)

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
por: Lenski, Marie, et al.
Publicado: (2021)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?
por: Crettol, Séverine, et al.
Publicado: (2007)

F227. PSYCHOLOGICAL TRAUMA OCCURRING DURING ADOLESCENCE IS ASSOCIATED WITH AN INCREASED RISK OF GREATER WAIST CIRCUMFERENCE IN EARLY PSYCHOSIS PATIENTS INDEPENDENTLY OF MEDICATION
por: Alameda, Luis, et al.
Publicado: (2018)

Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
por: Ansermot, Nicolas, et al.
Publicado: (2019)

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication
por: Alameda, Luis, et al.
Publicado: (2020)

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression
por: Delacrétaz, Aurélie, et al.
Publicado: (2015)

An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis
por: Perry, B., et al.
Publicado: (2022)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
por: Kuzo, Nazar, et al.
Publicado: (2022)

Do Adult Attachment Style or Personality Mediate the Relationship Between Childhood Maltreatment and Late-Life Depression in Poor Communities?
por: Gomes Jardim, Gabriel Behr, et al.
Publicado: (2022)

Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland
por: Reymann, Stephan, et al.
Publicado: (2022)

The role of self-regulatory control processes in understanding aggressive ideations and behaviors: An experience sampling method study
por: Plessen, Kerstin Jessica, et al.
Publicado: (2023)

The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants
por: Garin, Paul, et al.
Publicado: (2023)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Contributing to Eclipse : principles, patterns, and plug-ins /
por: Gamma, Erich
Publicado: (2004)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

Olanzapine Induced Hyponatraemia
por: Dudeja, Sonia J, et al.
Publicado: (2010)

Olanzapine-Induced Neutropenia
por: Malhotra, Kirti, et al.
Publicado: (2015)

Olanzapine-induced Psoriasis
por: Chepure, Ashish Hanmantrao, et al.
Publicado: (2017)

Seizure associated with olanzapine
por: Uvais, N. A., et al.
Publicado: (2018)

Contributing to Eclipse: principles, patterns, and plug-ins
por: Gamma, Erich, et al.
Publicado: (2003)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
por: Gastaldon, Chiara, et al.
Publicado: (2022)

Hyperglycemia associated with olanzapine treatment
por: Kumar, P. N. Suresh, et al.
Publicado: (2011)

Olanzapine induced tardive dystonia
por: Aggarwal, Ashish, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_aa49g79q4mkfs2i745b7rjrvd7